ホーム › 非小細胞肺癌 › フロリダ州 › Plantation
Plantation、FLにおける非小細胞肺癌の臨床試験
Plantationとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
被験者募集中第2/3相
- Florida Clinical Trials Group, Plantation
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
被験者募集中第3相
- Local Institution - 0935, Plantation
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
被験者募集中第3相
- BRCR Global, Plantation
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
被験者募集中第3相
- Florida Clinical Trials Group Plantation, Plantation
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- BRCR Global, Plantation
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
被験者募集中第3相
- Florida Clinical Trials Group., Plantation
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
被験者募集中第3相
- Clinical Study Site, Plantation
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
被験者募集中第3相
- BRCR Global Plantation, Plantation
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
被験者募集中第3相
- Florida Clinical Trials Group, LLC, Plantation
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
被験者募集中第3相
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- Boca Raton Clinical Research Associates, Plantation
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
被験者募集中第1相
- Florida Clinical Trials Group, Plantation
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
被験者募集中第2相
- BRCR Medical Center, Inc., Plantation
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- BRCR global, Plantation
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 101, Plantation
A Study of IBI363 in Subjects with Advanced Solid Malignancies
被験者募集中第2相
- BRCR Medical Center, Plantation
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Plantationにおける他の研究
- 乳がん14件の研究
- がん（全種類）7件の研究
- ループス7件の研究
- 肺がん7件の研究
- 転移性癌6件の研究
- 関節リウマチ6件の研究
- 前立腺がん5件の研究
- 乾癬性関節炎5件の研究
- 大腸癌5件の研究
- 悪性黒色腫4件の研究
- 多発性骨髄腫4件の研究
- 小細胞肺がん4件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。